BGC > Produktsuche > Loxoprofen ring-opening impurity | 1091621-61-2

Description:
Loxoprofen Ring-opening Impurity is a degradation product of Loxoprofen, a non-selective nonsteroidal anti-inflammatory drug (NSAID) that has been effective in reducing atherosclerosis in mice by reducing inflammation.

• Molecular Weight:278.3
• Purity:> 95%

Molecular Formula:
C15H18O5
Canonical SMILES:
CC(C1=CC=C(C=C1)CC(=O)CCCC(=O)O)C(=O)O
InChI:
InChI=1S/C15H18O5/c1-10(15(19)20)12-7-5-11(6-8-12)9-13(16)3-2-4-14(17)18/h5-8,10H,2-4,9H2,1H3,(H,17,18)(H,19,20)
InChIKey:
ALZUIVGLLMTAMW-UHFFFAOYSA-N
Synonyms:
4-(1-Carboxyethyl)-δ-oxo-benzenehexanoic Acid; 2-[4-(2-Oxo-6-carboxy-pentyl)phenyl-propanoic Acid